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Autophagy adjusts cellular biomass and function in response to diverse stimuli, including infection. Autoph-
agy plays specific roles in shaping immune system development, fueling host innate and adaptive immune
responses, and directly controlling intracellular microbes as a cell-autonomous innate defense. As an evolu-
tionary counterpoint, intracellular pathogens have evolved to block autophagic microbicidal defense and
subvert host autophagic responses for their survival or growth. The ability of eukaryotic pathogens to deploy
their own autophagic machinery may also contribute to microbial pathogenesis. Thus, a complex interplay
between autophagy and microbial adaptations against autophagy governs the net outcome of host-microbe
encounters.Introduction
Autophagy is a fundamental biological process that simulta-
neously touches on multiple aspects of eukaryotic cells and
metazoan organisms. In its most generic rendition, autophagy
is a process that controls the quality and quantity of intracellular
biomass in eukaryotic cells by targeting for autodigestion cyto-
plasmic components that range in complexity and size from indi-
vidual proteins to whole organelles. At one end of the spectrum,
a delicate process termed chaperone-mediated autophagy di-
rectly imports individual cytosolic proteins that contain specific
recognition motif sequences into the lysosome. At the other
end of the spectrum, macroautophagy acts as a bulk process
that captures large portions of the cytosol or sequesters big
organelles such as mitochondria and peroxisomes (Figure 1).
The general term ‘‘autophagy’’ usually denotes canonical macro-
autophagy characterized by its marquee feature, the double-
membrane autophagosome. It has also become increasingly
evident that autophagy, through its regulators comprised of
Atg (Autophagy) and additional factors, interacts in a number
of previously unappreciated ways with other pathways and
processes in the host cell that do not always easily fit under
‘‘autophagy’’ as defined above. In these secondary roles, Atg
proteins interact with other systems in the cell to coordinate
various cellular functions (including immunological processes)
with classical autophagy functions. Of note, it has also been
proposed that Atg factors may have yet a third set of functions
completely unrelated to autophagy or coordination between
autophagy and other systems, referred to as autophagy-inde-
pendent functions of Atg genes (Virgin and Levine, 2009).
A rapidly developing area of autophagy research is the study
of immunological functions of autophagy (Levine and Deretic,
2007; Munz, 2009). Since the known immunological functions
of chaperone-mediated autophagy (e.g., major histocompati-
bility complex [MHC] II-restricted endogenous antigen presenta-
tion) overlap with a subset of macroautophagy roles, for the
purpose of this review, chaperone-mediated autophagy willnot be distinguished from macroautophagy. Macroautophagy,
which is usually referred to simply as autophagy (with the caveat
in the above paragraph), is controlled by several signaling sy-
stems relaying nutritional or stress inputs to the core executioner
machinery composed of Atg factors, which in turn drive the
generation of autophagic organelles to sequester and degrade
cytoplasmic targets (Figures 1A and 1B). This homeostatic role
of autophagy affects cell survival (Kroemer and Levine, 2008),
is reflected in the complexity of its regulation (Figure 1C), and
represents the underpinnings of the role of autophagy in health
and disease (Levine and Kroemer, 2008; Mizushima et al.,
2008), including aging, cancer, neurodegenerative disorders,
immunity, infectious diseases, and chronic inflammatory condi-
tions such as Crohn’s disease (CD).
The multilayered intersections (Figure 1D) between immunity
and autophagy (the term autophagy being used here in a broad
sense, including all functions of Atg factors) span phenomena
ranging from cell-autonomous defenses to functions of the entire
immune system and can manifest themselves in adaptive and
innate immunity, in regulatory and effector immune functions,
and in tolerance versus immune activation and inflammation.
At the level of the whole immune system, autophagy contributes
to positive and negative selection of the CD4 T cell repertoire
(Nedjic et al., 2008) and T and B cell homeostasis (Li et al.,
2006; Miller et al., 2008; Pua et al., 2007; Pua and He, 2007).
Autophagy enables endogenous MHC II antigen presentation
(Schmid and Munz, 2007), thus governing thymic selection and
central tolerance (Nedjic et al., 2008). This function of autophagy
involves the delivery of cytosolic proteins to the lumen of MHC II
antigen processing and loading compartments, extends to MHC
I presentation (English et al., 2009), affects generation of optimal
immune responses to pathogens, and may be of significance for
vaccine development (Jagannath et al., 2009; Schmid et al.,
2007). Autophagy is furthermore an effector of Th1/Th2 polariza-
tion enabling (Andrade et al., 2006; Gutierrez et al., 2004; Ling
et al., 2006) or disabling macrophages to utilize autophagy inCell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 527
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(A) Electron micrograph comparing the appearance of an autophagosome (1) versus autolysosome (2) with conventional lysosomes (Ly).
(B) A composite of autophagic membrane formation (schematic) with actual autophagosome from an electron micrograph. Three stages can be discerned by
ultrastructural morphology: initiation (crescent membrane decorated on both sides with Atg protein-lipid [Atg8-PE; known as LC3-II] and protein-protein528 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.
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immunity, autophagy is both a regulator (Jounai et al., 2007;
Lee et al., 2007; Tal et al., 2009) and an effector of pattern recog-
nition receptor (PRR) responses to pathogen- (Delgado et al.,
2008; Sanjuan et al., 2007; Xu et al., 2007; Yano et al., 2008)
and possibly to danger-associated molecular patterns (PAMPs
and DAMPs, respectively) (Biswas et al., 2008; Saitoh et al.,
2008). Furthermore, autophagy acts as a cell-autonomous de-
fense directly eliminating intracellular microbes or their products,
including bacteria, viruses, and protozoa (Levine and Deretic,
2007), in a process termed xenophagy (Levine, 2005).
Clearly, our knowledge of the immunological functions of au-
tophagycontinues to rapidly increase inscopeanddiversity (Levine
andDeretic, 2007). This review summarizeswhat has been learned
regarding the role of autophagy in various branches of immunity
and delves into the mechanisms as they pertain to host-pathogen
interactions.We explore in depth the status of autophagy as a cell-
autonomous innate immunity defense against intracellular patho-
gens vis-a`-vis adaptations that have evolved in pathogens to
counter autophagy. These adaptations enable successful intracel-
lular parasites to effectively protect themselves against autophagic
inhibition or degradation and evenharness autophagy for their own
replication.We also highlight another emerging theme: intracellular
eukaryotic parasites undergo autophagy themselves, leading to
situations where autophagy contributes to both sides of the
struggle in host-pathogen interactions.
Autophagy in the Host Cell
The cellular process of autophagy evolved at the beginning of
eukaryotic life. The ability of viruses and bacteria to gain access
to the interior of the eukaryotic cell generated selective pres-
sures for the development of an effective cellular mechanism
to dispose of such microbes. In this context, autophagy may
have evolved as a primordial antimicrobial defense mechanism
that can degrade intracellular parasites. At the transition tometa-
zoan life, with the evolution ofmore specialized cells and immune
systems, the functions of autophagy broadened so as to main-
tain its role at the nexus of more complex immune systems.
Not only does autophagy function in a cell-autonomous manner
to degrade intracellular pathogens, it also helps orchestrate the
systemic immune response by functioning as a regulator of
innate immunity, adaptive immunity, and inflammation. In this
section, we will provide an overview of autophagy in the host
cell, with an emphasis on its core molecular mechanisms, its
broad roles in immunity, its newly emerging roles in the control
of inflammation, and its most primal role as a cell-autonomous
mechanism for eliminating intracellular microbes.
Autophagy as a Cell Biological Process
A key morphological manifestation of autophagy is the formation
of autophagic organelles in the cytoplasm. They begin as short-lived membrane crescents, termed phagophores or isolation
membranes, which give rise to double-membraned autophago-
somes (Figure 1B). The autophagosomes undergo maturation
into autolysosomes by fusion with lysosomal organelles, fol-
lowed by loss of the inner of two membranes and degradation
of the captured cytoplasmic target(s). While autophagosomes
are considered the morphological hallmark of autophagy, their
turnover is quite rapid, and often what are actually seen by elec-
tron microscopy are autolysosomes. Typically, these structures
are delimited by a single membrane and contain lumens packed
with remnants of cytoplasmic components, including shredded
membranes and electron-dense material from decomposing
ribosomes (Figure 1A). The origin of the autophagosomal phag-
ophore membrane is not known with certainty, but both older
and more recent data suggest involvement of the endoplasmic
reticulum (ER) (Axe et al., 2008; Matsunaga et al., 2009).
Autophagosome formation is believed to be driven by two
protein-protein and protein-lipid conjugation systems (Fig-
ure 1B). The first system yields an Atg5-Atg12 covalent conju-
gate that associates noncovalently with Atg16L1 (the mamma-
lian equivalent of yeast Atg16) to form a putative E3 enzyme
(terminology borrowed from the ubiquitin system) (Hanada
et al., 2007), directing the site of the formation of the second
protein-lipid conjugate (Fujita et al., 2008). The second system
yields LC3-II (Atg8-PE), which has phosphatidylethanolamine
at its C terminus that allows it to associate with or assist in auto-
phagic membrane growth. Once formed and membrane-bound,
LC3-II becomes an autophagosomal structural protein that
executes other functions by interacting with the WXXL motif in
the adaptor molecules p62 (Pankiv et al., 2007) and NBR1 (Kirkin
et al., 2009), which capture cytoplasmic cargo earmarked for au-
tophagic degradation, such as protein aggregates that are too
large for proteasomal degradation. The partnering of LC3 with
p62 and NBR1 suggests one potential mechanism by which au-
tophagic targets may be recognized. Although it is not known
whether these tag-receptor pairs are ubiquitously used to slate
other targets, such as organelles, for autophagy, monoubiquti-
nation has been shown to be sufficient to target an ectopically
expressed cytoplasmic protein as well as peroxisomes for
autophagic degradation (Kim et al., 2008). To date, no molecular
tags of this nature have been reported on a microbe to guide
autophagosomes with precision to their microbial targets.
However, it is reasonable to speculate that some of the same
molecular tags used to deliver cytoplasmic constituents may
also be used to deliver microbes to the autophagosome. Yet
PAMPs released by microbes stimulate autophagy (Delgado
et al., 2009; Yano et al., 2008), and we cannot exclude the possi-
bility that the execution stages of the process may be more
stochastic and less perfectly guided toward specific microbial
targets.conjugates [Atg12-Atg5, complexed with Atg16]), elongation (growth of isolationmembrane) ending in its closure to form an autophagosome, andmaturation that
involves the formation of degradative autolysosomes through fusion of autophagosomes with lysosomal organelles (electron-dense granular material represents
ribosomal degradation intermediates). All micrographs in (A) and (B) are courtesy of Eeva-Lisa Eskalinen (reproduced with permission).
(C) Two signaling systems control induction of autophagy: left, hVps34-Beclin 1; right, Tor-Atg1. Various signals and systems transmitting them that lead to au-
tophagy activation are shown in smaller boxes. Rapamycin induces autophagy by inhibiting Tor, and some immune signals that are transmitted via TLR adapters
MyD88 and TRIF or DAPK downstream of IFNg lead to activation of Beclin 1 (complexed with the phosphatidylinositol 3 kinase hVps34) by its dissociation from
Bcl-2. Note that starvation, a classical inducer of autophagy, affects both Bcl-2-Beclin 1 complex (via JNK1) and Tor activity. Th2 cytokines and many growth
factors in general inhibit autophagy via Tor (or in the case of immunologically induced autophagy, e.g., by IFNg, via Stat-6 downstream of IL-4/IL-13).
(D) Immunological inputsandoutputsofautophagy.Xenophagy,autophagicmacrophageactivation,additional terms, factors,andrelationshipsaredescribed inthe text.Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 529
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through protein and lipid kinase signaling cascades that regulate
autophagy converge upon two key signaling nodes (Figure 1C):
(1) Tor-Atg1 and (2) Beclin 1(Atg6)-hVps34. The Tor-Atg1 system
transduces growth, nutritional, and some stress signals to initiate
autophagy. The metabolic aspects of autophagy are under
negative control by the growth factors, insulin receptor su-
bstrate, type I phosphatidylinositol 3 kinase (PI3K), Akt/PKB,
and the downstream Tor-Atg1 signaling cascade. How Atg1
sets in motion other Atg factors and downstream morphologi-
cally distinguishable events is still not completely clear. It
possibly regulates multiprotein complex formation involving
a number of other Atg proteins initially recognized only in yeast
(Kawamata et al., 2008), but which now appear to have counter-
parts in mammalian cells (Hosokawa et al., 2009).
The Beclin 1-hVps34 represents another key regulatory node
centered on an ancient stress-signaling lipid kinase, known as
type III PI3K Vps34. The exact role of the enzymatic product of
hVps34 is not fully understood, but it likely plays a pivotal role
in early autophagosomal membrane formation (Axe et al.,
2008), the targeting of PI3P-binding proteins such as Atg18 to
the autophagic membrane (Obara et al., 2008), the localization
of LC3 lipidation (Fujita et al., 2008), and autophagosomal matu-
ration into autolysosomes (Liang et al., 2008). Beclin 1 is a key
regulator of autophagy, and it exists in functionally distinct
hVps34-containing protein complexes (Figure 1C), including
several modifier components: (1) Atg14, which plays a role in
initiation (Itakura et al., 2008; Matsunaga et al., 2009; Zhong
et al., 2009), and (2) UVRAG/VPS38, which plays a role in matu-
ration (Itakura et al., 2008; Liang et al., 2008) and is negatively
regulated by Rubicon (Matsunaga et al., 2009; Zhong et al.,
2009). Beclin 1 complexes can contain several additional factors
such as Ambra1 (Fimia et al., 2007) and Bif-1/Endophilin B1
(Takahashi et al., 2007) that may further modulate its function.
Many signals that lead to autophagy activation affect Beclin 1
as the ‘‘nerve center’’ of autophagic control. This includes stress
and immunological inputs such as activation by JNK1 kinase
(Wei et al., 2008), shown to activate Beclin 1 downstream of star-
vation (but possibly engaged during innate immune signaling);
DAPK (Zalckvar et al., 2009), a kinase activated downstream of
IFNg stimulation; BH3-only proteins such as Bnip3 (in turn regu-
lated by FoxO3 in atrophy or by HIF-1 in hypoxia) (Zhang et al.,
2008); and MyD88, reported to occur downstream of PRR stim-
ulation by microbial products (Shi and Kehrl, 2008).
Broad Connections between Autophagy and Immunity
The repertoire of autophagy’s functions in immunity has been
expanding at an extraordinary pace. The broad immunological
roles of autophagy (Figure 1D), collectively dubbed ‘‘immunoph-
agy’’ (Deretic, 2006), can be categorized as: (1) regulatory versus
effector roles, (2) innate versus adaptive immunity functions, (3)
Anti-inflammatory versus proinflammatory, and (4) specialized
immune-cell-specific versus generic cellular homeostatic roles
that are applicable to immune cells.
Among the innate immunity effector functions, the most
intrinsic to autophagy (i.e., the engulfment and lysosomal degra-
dation of cytoplasmic components) is its role in direct elimination
of intracellular microbes (Figure 1D). This process can manifest
itself as xenophagy (Levine, 2005), denoted to describe direct
autophagy of intracellular microbes in any cell type. Here, we530 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.introduce ‘‘autophagic macrophage activation’’ (APMA) as a
general term to denote a collection of autophagy-related
processes in cells of the reticulo-endothelial system. APMA
includes (1) convergence of phagocytosis and the autophagic
machinery (Sanjuan et al., 2007), (2) enhanced microbicidal
properties of autolysosomes in comparison to standard phago-
lysosomes (Alonso et al., 2007), (3) autophagic modulation of
PRR signaling (Delgado et al., 2008; Sanjuan et al., 2007; Shelly
et al., 2009; Xu et al., 2007), (4) cooperation between immunity
related GTPases and autophagy or Atg factors in attacking para-
sitophorous vacuoles (Gutierrez et al., 2004; Ling et al., 2006;
Singh et al., 2006; Zhao et al., 2008), and (5) enhanced antigen
presentation (Schmid et al., 2007; English et al., 2009). APMA
is thus recognized as a complex outcome of autophagy stimula-
tion in macrophages, representing a unique composite process
bringing about a heightened state of activation.
Autophagy in Innate Immunity
The innate immunity functions identified to date encompass both
effector outputs (Delgado et al., 2008; Sanjuan et al., 2007; Shelly
et al., 2009; Xu et al., 2007) and regulatory roles, some of which
are in conjunction with PRRs (Jounai et al., 2007; Lee et al.,
2007; Saitoh et al., 2008; Tal et al., 2009). As a regulator of immu-
nity responses, autophagy acts in several ways (Figure 1D).
Autophagy is proinflammatory, e.g., when autophagy captures
cytosolic viral replication intermediates and delivers them to the
lumen of endosomal compartments where they meet their
cognate PRRs, as in the case with viral single-stranded RNA
and Toll-like receptor (TLR) 7 (Lee et al., 2007). Complementarily,
autophagy can also dampen proinflammatory responses,
including IL-1b, IL-18 (Saitoh et al., 2008), and type I IFN produc-
tion (Jounai et al., 2007; Tal et al., 2009) (Figure 1D). As an
effector, autophagy is modulated by cytokines (Figure 1D),
including IFNg, TNF-a, IL-4, and IL-13, and acts as an output of
both innate and adaptive immunity responses (Deretic, 2009).
The autophagic machinery can be activated upon detection of
PAMPs by their cognate PRRs (Delgado et al., 2008; Sanjuan
et al., 2007; Shelly et al., 2009; Xu et al., 2007; Yano et al.,
2008) or antibody-Fcg receptor (Huang et al., 2009). The signal
transduction pathways between agonist-stimulated receptors
and autophagy activation remain to be fully delineated. This is
an important frontier, especially since there have been reports
of the inability to detect macroautophagy downstream of TLR
stimulation (Saitoh et al., 2008) and discrepancies in adaptor
usage downstream of certain PRRs in the context of autophagy
(Delgado et al., 2008; Sanjuan et al., 2007; Xu et al., 2007). PRR
signaling to autophagy may involve the reported complex
formed between the TLR adaptors (MyD88 and TRIF) and Beclin
1 and changes in the antiapoptotic protein Bcl-2’s interaction
with Beclin 1 upon TLR stimulation (Shi and Kehrl, 2008)
(Figure 1D), akin to Bcl-2-Beclin 1 interactions observed during
activation of autophagy by nonimmunological signals (Wei
et al., 2008) (Figure 1C).
Autophagy can also be activated by reactive oxygen species
(ROS) (Scherz-Shouval et al., 2007). Accordingly, ROS produced
by NADPH oxidase downstream of TLR or Fcg receptor stimula-
tion in phagocytes has been shown to activate autophagy
(Huang et al., 2009). The report from Sanjuan et al. that LC3-II
appears on phagosomes without the appearance of conven-
tional double membranes shortly after particle uptake when
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to the unconventional roles of Atg proteins. However, the coac-
tivation of NADPH oxidase andROS production during phagocy-
tosis of opsonized or PAMP-laden particles may in essence
mirror the observed induction of autophagy by mitochondrially
produced ROS in response to starvation stimuli (Scherz-Shouval
et al., 2007) and may explain in part the observations of Sanjuan
et al. These eventsmay be best understoodwithin the concept of
APMA, as proposed earlier, which is a set of linked events in
macrophages and includes connections between ROS produc-
tion and autophagy.
Importantly, autophagy induction downstream of PRR activa-
tion is countered by NF-kB, which is activated concomitantly
(Djavaheri-Mergny et al., 2006) (Figure 1D). This may explain
why PAMPs do not uncontrollably stimulate autophagy in phys-
iological situations (Delgado et al., 2008) and a report that au-
tophagy could not be detected upon PRR stimulation (Saitoh
et al., 2008). Independent of its antimicrobial function, autoph-
agy induced by LPS and TLR4 may act to protect against LPS
cytotoxicity, which is of potential relevance for countering my-
ocardial depression in septic shock (Yuan et al., 2009). Other
innate immunity mediators such as IL-1b, a proinflammatory
cytokine normally generated upon inflammasome activation
with PAMPs or the host’s own DAMPs, can also stimulate au-
tophagy (English et al., 2009) (Figure 1D). Consistent with the
direct involvement of DAMP pathways, ATP, which is an endog-
enous activator of the inflammasome, can stimulate autophagy
through the P2X7 receptor (Biswas et al., 2008). Thus, both
microbial PAMPs and host DAMPs appear to be linked to
autophagy.
Autophagy in Adaptive Immunity
We are only just beginning to comprehend what appear to be
the critical functions of autophagy in regulating adaptive
immune responses, immunological tolerance, and the develop-
ment and homeostasis of the immune system. At least three
distinct processes contribute to these functions (Figure 1D).
(1) Autophagy, by the very nature of its ability to capture cyto-
plasmic proteins, supports MHC II-restricted endogenous
antigen presentation of cytosolic self or microbial (e.g., viral)
antigens synthesized by host cells (Gannage and Munz, 2009).
It may likewise influence MHC I presentation of viral antigens
in a process occurring separately from and following the initial
canonical ER-dependent cross-presentation pathway (English
et al., 2009). (2) Autophagy shapes central tolerance via thymic
selection of the T cell repertoire (Nedjic et al., 2008). (3) Auto-
phagy also affects homeostasis of T cells (Pua et al., 2009),
B cells (Miller et al., 2008), and specialized granulocytes of
the intestinal epithelium known as Paneth cells (Cadwell et al.,
2008).
Some additional functions of autophagy may represent more
of a ‘‘fine tuning’’ of the immune response. For example, autoph-
agy acts as an effector of immune phenomena such as Th1/Th2
polarization; when induced by Th1 cytokines such as TNF-a
(Djavaheri-Mergny et al., 2006) or IFNg (Harris et al., 2007), mac-
roautophagy (i.e., xenophagy) and APMA kill intracellular
microbes (e.g., M. tuberculosis), while Th2 cytokines such as
IL-4 and IL-13 inhibit autophagy and protect intracellular patho-
gens form autophagic elimination (Harris et al., 2007). Addition-
ally, in the context of vaccine development, autophagy has beenused to enhance CD4 T cell responses to influenza matrix
protein (Schmid et al., 2007) and to enhance BCG vaccine effi-
cacy in animal models of tuberculosis (Jagannath et al., 2009).
These studies open a new area of translational research in
the application of autophagy in prophylaxis against infectious
diseases.
Autophagy in Inflammation
Certain immune responses act as a double-edged sword, either
resolving infection or leading to over-exuberant inflammation
and tissue damage. Autophagy belongs to this category, in
view of the developing connection between inflammatory bowel
disease and mutations in autophagy (e.g., ATG16L1) or autoph-
agy-related (e.g., IRGM) genes, as predisposition loci in CD that
have been identified in human populations through whole
genome association studies (GWAS) (McCarroll et al., 2008;
Parkes et al., 2007; Wellcome Trust Case Control Consortium,
2007) (Figure 2). Genetic risks in CD were linked some time
ago to innate immunity via Nod2, which like many other PRRs
recognizes bacterial products of the enteric flora (Kanneganti
et al., 2007). Interestingly, several risk loci identified through
GWAS are common to ulcerative colitis and CD, but autophagy
genes ATG16L1 and IRGM, along with NOD2, appear to be
more specific for CD (Fisher et al., 2008), and IRGM risk alleles
may predispose even more specifically to the ileal form of CD
(Roberts et al., 2008). ATG16L1 is a part of the basal autophagy
apparatus, while IRGM is a member of the vertebrate family of
innate immunity effectors called immunity-related GTPases
(IRGs) (Bekpen et al., 2009). In the mouse, there are multiple
IRG genes, while humans and chimpanzees have only one
IRG, IRGM (Bekpen et al., 2009). The human IRGM (Singh
et al., 2006) and murine Irgm1 (Gutierrez et al., 2004) and Irga6
(Al-Zeer et al., 2009; Ling et al., 2006; Zhao et al., 2008) have
all been shown to play a role in autophagic elimination of intracel-
lular pathogens.
Functional information regarding the role of autophagy in hu-
mans in the context of CD is lacking. Nevertheless, relevant infor-
mation regarding ATG16L1 has been obtained in studies at the
cellular level and in vivo in mice, with three published studies
identifying different effects that may be additive (Figure 2, middle
panel): (1) a diminished capacity of the CD risk ATG16L1*300A to
control intracellular enteric pathogens (Kuballa et al., 2008),
which fits with the current focus on adherent-invasive E. coli
(AIEC) as one of the microbial culprits in CD (Rolhion and Dar-
feuille-Michaud, 2007); (2) increased susceptibility of Atg16L1-
deficient mice to chemically-induced colitis that is linked to
elevated IL-1b signaling (Saitoh et al., 2008); and (3) direct or
indirect effects in Atg16L1 hypomorphic mice on Paneth cells
(Cadwell et al., 2008), the epithelial-type stationary ‘‘granulo-
cytes’’ of the intestinal crypt that guard the overhead stem cell
zone from microbial penetration, a long-time suspect in the
etiology of CD. The role of IRGM cannot be properly investigated
in mice, as the mouse has 19 IRGM-like genes. Human IRGM
plays a direct role in antibacterial defenses (Singh et al., 2006),
which fits well with a similar role of ATG16L1 in the control of
intracellular enteric bacteria (Kuballa et al., 2008). However,
additional processes cannot be excluded, given that Irgm1,
one of the three putative murine orthologs, shows effects on
hematopoietic stem cell proliferation and T cell survival (Feng
et al., 2008a, 2008b).Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 531
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Top shows two autophagy factors identified as Crohn’s disease (a form of inflammatory bowel disease) susceptibility loci. The IRGM gene has single nucleotide
polymorphisms (SNP) and a 20 kb deletion in the promoter region associated with CD.ATG16L1 alleles encode either a protective ATG16L1*300T or a risk form of
ATG16L1*300A (CCD, coiled coil domain; green boxes, WD repeats domain [absent in yeast Atg16]). Middle panel shows intestinal epithelium with different cell
types along with the proposed functions of autophagy in the ileal epithelium. Side box shows that thymic selection of naive T cell repertoires depends on autoph-
agy, and autophagic anomalies may contribute to inflammation at peripheral sites such as intestinal mucosa. Bottom box lists 3 different effects reported for
Atg16L1 (mouse) or ATG16L1 (human epithelial cells) mutations. ATG16L1*300A has been tested in cell lines. Atg16L1HM, hypomorphic Atg16L1 allele, and
Atg16LDCCD construct have been tested in vivo in transgenic mice.Finally, a comprehensive explanation for the role of autophagy
in inflammatory processes, including CD, needs to take into
account the endogenous antigen presentation process, whereby
thymic epithelial cells present endogenous (self) antigens to
developing T cells, influencing their positive and negative selec-
tion (Nedjic et al., 2008). Thus, autophagy, through appropriate
selection of naive T cells (Figure 2, middle panel) before they
exit to the periphery, serves as a guardian of immunological toler-532 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.ance. This seems to be exceptionally important, as when this
process is rendered dissonant between the periphery and the
thymus inmicewithAtg5/ thymic implants, theanimalsdevelop
multiorgan inflammation, including colitis. It remains to be seen
whether aberrant autophagy (e.g., risk alleles in CD or yet to be
identified potential autophagy defects in other autoimmune or
inflammatory diseases) may lead to dissonant thymic selection
vis-a`-vis endogenous antigen presentation in the periphery.
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Defense System
Since autophagosomes can engulf large portions of the cytosol
and digest whole organelles such as mitochondria, it is intuitively
compelling to think of this process as capable of capturing and
eliminating intracellular microbes. Conclusive demonstrations
ex vivo and in vivo of this concept, however, have proven less
than trivial. A forerunner to the development of this field was
a report that ectopic Beclin 1 expression in neurons suppresses
viral replication in the brain and reduces morbidity and mortality
in experimental animals (Liang et al., 1998). In more recent years,
a growing number of microorganisms have been demonstrated
to be subject to elimination by autophagy in vitro involving one
or more of the processes listed in Figure 3, upper left panel.
Only very recently has the autophagic machinery been shown
to protect against thus far a small number of infectious diseases
in vivo (Table 1). In addition, autophagy may protect host cells
against toxic products produced by pathogens, such as Vibrio
cholerae cytolysin (Gutierrez et al., 2007), Bacillus anthracis
lethal toxin (Tan et al., 2009), and Helicobacter pylori vacuolating
toxin (Terebiznik et al., 2009) (Figure 3 and Table 1).
Among viruses, autophagic protection has been shown for
vesicular stomatitis virus (VSV) (Shelly et al., 2009), tobacco
mosaic virus (TMV) (Liu et al., 2005), herpes simplex virus 1
(HSV-1) (Orvedahl et al., 2007), and human immunodeficiency
virus (HIV) (Kyei et al., 2009). HSV-1 and HIV fall prey to autoph-
agy when they are disarmed by inactivation of their specific
antiautophagy factors, ICP34.5 and Nef, respectively (Orvedahl
et al., 2007; Kyei et al., 2009). Among bacteria, microbes that
can invade into host cells (e.g., Gram-positive extracellular path-
ogens such as Streptococcus pyogenes [Nakagawa et al., 2004]
or facultative intracellular pathogens such as M. tuberculosis
[Alonso et al., 2007; Biswas et al., 2008; Gutierrez et al., 2004;
Singh et al., 2006], Salmonella [Birmingham et al., 2006], and Lis-
teria monocytogenes [Py et al., 2007; Yano et al., 2008; Zhao
et al., 2008]) can be eliminated through autophagy. However,
as with viruses, the highly evolved intracellular bacterial patho-
gens possess antiautophagic factors, exemplified by Shigella,
where inactivation of the bacterial type III secretion system
(T3SS)-dependent effector IcsB is prerequisite to elimination
by autophagy (Ogawa et al., 2005). Among protozoans, in vitro
and in vivo data exist to support a role for autophagy and/or
the autophagic genes in defense against Toxoplasma gondii
(Andrade et al., 2006; Ling et al., 2006; Zhao et al., 2008). These
examples underscore two concurrent phenomena: (1) autoph-
agy acts as a defense against microbes when they manage to
invade the host cell interior, and (2) highly evolved intracellular
pathogens have adaptations to protect themselves from auto-
phagic elimination or even harness the host cell autophagic
machinery to their own benefit, as will be covered in more detail
in subsequent sections.
It is important to keep in mind the above phenomena in inter-
preting reports using highly adapted intracellular pathogens, as
even when the specific antiautophagic adaptations are not yet
known, they may exist. Until such factors are identified and
inactivated, the true power of autophagic action in eliminating
microbes may remain masked. In this context, experiments
where pathogens and hosts are slightly ‘‘mismatched’’ are co-
nducive to observing autophagy in action, which may be other-wise obscured due to evolutionary adaptations in finely tuned
host-pathogen pairs. Examples of this come from using
Drosophila to study mammalian pathogens, where infection ex-
periments with L. monocytogenes (Yano et al., 2008) and VSV
(Shelly et al., 2009) unambiguously demonstrate that autophagy
controls these microbes in vivo. Mouse infection models of
human disease have also led to the demonstration of autopha-
gy’s role in vivo, as shown in recent experiments with viruses
(Orvedahl et al., 2007) and protozoans (Zhao et al., 2008). The
study by Zhao et al. with T. gondii infection using Atg5Flox/Flox
LysM-Cre mice (with an Atg5 defect specifically in monocytic
cells) has shown that Atg5 function is key in controlling this path-
ogen in vivo. The details of the study revealed a complex relation-
ship between Atg5 and IRG (in this case Irga6)-dependent
processes (Zhao et al., 2008), perhaps not unlike what has
been seen with Irgm1 (MacMicking et al., 2003) and autophagy
in controlling M. tuberculosis (Gutierrez et al., 2004). The exact
details of how IRG and Atg factors work together or whether
they work sequentially (e.g., with Atg5 preceding Irga6 recruit-
ment, as implicated in the studies with Irga6 [Al-Zeer et al.,
2009; Zhao et al., 2008]) remains to be delineated. Finally,
whereas animal experiments remain of high significance to define
further the full spectrum of autophagy in antimicrobial defense,
GWAS in human populations are of equal interest in exploring
whether polymorphisms in autophagy genes predispose to
certain infectious diseases, as has been observed with CD.
Microbial Adaptations to Host Autophagy
Microbial pathogens that successfully parasitize eukaryotic cells
(i.e., intracellular pathogens) have evolved in the setting of selec-
tive pressures imposed by cellular autophagy as a pathway
central to innate and adaptive immunity. Consequently, it is not
surprising thatmicrobeshavedevelopedmultipronged strategies
to avoid autophagolysosomal degradation and/or to dampen au-
tophagy-dependent activation of host immune responses (Fig-
ure 3, bottom panel). Researchers are beginning to delineate
such molecular strategies and their potential roles in microbial
pathogenesis, although in most cases, our understanding of
this area is still quite rudimentary. The types of microbial adapta-
tions identified todatecanbebroadlycategorizedasstrategies to
(1) prevent the induction of autophagy, (2) prevent thematuration
of the autophagosome into an autolysosome, (3) avoid pathogen
recognition by the autophagicmachinery, and (4) utilize functions
or components of autophagy to enhance intracellular survival,
replication, or extracellular release of intracellular pathogens.
Microbial Suppression of Autophagy Induction
As discussed, the activation of autophagy in an infected cell may
represent a fairly ubiquitous response triggered by PRRs that
recognize microbe-specific PAMPs. While most studies have
been performed using TLR ligands (rather than intact microbes)
(reviewed in Delgado et al., 2009), PRR-dependent autophagy
induction has recently been shown to protect against L.monocy-
togenes infection in Drosophila (Yano et al., 2008). It is not yet
known whether pathogens possess strategies to block PRR-
dependent autophagy induction or how ubiquitously PRRs are
used to activate autophagy. What appears more likely, at least
based on the limited research to date, is that microbial adapta-
tions to suppress autophagy induction may be focused on tar-
geting some of the more general (i.e., not pathogen-specific)Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 533
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agy. This evidence stems largely from studies done with the
three major groups of herpesviruses, the a-, b-, and g-herpesvi-
ruses, although the principles learned from such studies are
likely to be extrapolatable to other virus families and perhaps
to other types of microbial pathogens.
Herpesviruses block autophagy induction through at least
three distinct mechanisms (Table 2 and Figure 3, bottom panel),
including blockade of autophagy-stimulatory PKR/eIF2a kinase
signaling (Figure 1D) (through HSV-1 ICP34.5-mediated eIF2a
dephosphorylation) (Tallo´czy et al., 2002), blockade of the au-
tophagy function of Beclin 1 (through HSV-1 ICP34.5, KSHV,
or murine g-HV68 viral Bcl-2 binding of Beclin 1) (Ku et al.,
2008a; Orvedahl et al., 2007; Pattingre et al., 2005; Sinha et al.,
2008), or activation of autophagy-inhibitory mTOR signaling (by
human cytomegalovirus through an as of yet undefined mecha-
nism) (Chaumorcel et al., 2008) (Figure 3, bottom panel). The utili-
zation of different strategies for preventing autophagy induction
by a single viral virulence protein (i.e., HSV-1 ICP34.5 blocks
both eIF2a phosphorylation and Beclin 1 function), the utilization
of different viral structuralmotifs for targetingBeclin 1 (i.e., HSV-1
ICP34.5 and viral Bcl-2 proteins both bind Beclin 1, but share
no structural similarity with each other and bind to nonoverlap-
ping regions of Beclin 1), and the prevention of autophagy induc-
tion by all three classes of herpesviruses likely underscore a
critically important role for evasion of autophagy in herpesvirus
pathogenesis. Indeed, for HSV-1, it has been shown that
ICP34.5-mediated blockade of Beclin 1-dependent autophagy
is essential for lethal HSV-1 encephalitis (Orvedahl et al., 2007).
The role of CMV and g-herpesvirus evasion of autophagy in viral
pathogenesis has not yet been explored, but considering that
autophagy is a tumor suppressor pathway (Levine and Kroemer,
2008; Mizushima et al., 2008), it is tempting to speculate that
g-herpesvirus evasion of autophagy might contribute to viral
oncogenesis. Another open question is whether other virus fami-
lies also inhibit autophagy induction; given the numerous viral
proteins encoded by the diverse families of viruses that have
already been shown to inhibit PKR/eIF2a kinase signaling or to
activate mTOR signaling (reviewed in Cooray, 2004 and Sadler
and Williams, 2008), it seems likely that suppression of host
autophagy induction signaling pathways will be a fairly universal
feature of viral infections.
It is not yet clear whether other intracellular pathogens besides
viruses also actively suppress initiation of the autophagy
pathway or rather focus uniquely on blocking pathogen recogni-
tion by autophagosomes and/or the maturation of pathogen-
containing autophagosomes into acidified autolysosomes.
Certain bacterial virulence factors (such as Listeria-encoded
Prf1-regulator factors, ActA and phospholipases [Birmingham
et al., 2007; Py et al., 2007], Burkholderia pseudomallei BopA
[Cullinane et al., 2008], and Shigella-encoded IcsB [Ogawa
et al., 2005]) are necessary for bacterial evasion of autophagy,
as defined either by increased colocalization with GFP-LC3 or
increased growth of replication-deficient bacterial mutants in
autophagy-deficient cells. However, to date, there is no pub-
lished evidence indicating that bacteria, fungi, or parasites block
the induction of autophagy in infected cells (although a microar-
ray analysis of Francisella tularensis-infected macrophages
revealed downregulation of several autophagy genes [Butcharet al., 2008]). Moreover, in many reports, autophagy induction
can be enhanced in bacterially infected cells by starvation or
rapamycin, suggesting the absence of microbial mechanisms
that can completely block autophagy induction. Nonetheless, it
remains an open question whether nonviral pathogens suppress
autophagy induction. An interesting possibility is that the known
activity ofM. tuberculosis in the inhibition of hVps34/PI3-depen-
dent trafficking pathways in macrophages (Vergne et al., 2004)
may extend to inhibition of the Beclin 1/hVps34 autophagy
complex. At yet another level, highly virulent strains ofM. tuber-
culosis elicit more IL-4 and IL-13 (Manca et al., 2004), the Th2
cytokines known to inhibit autophagy (Petiot et al., 2000), and
suppress aspects of APMA (Harris et al., 2007). Other important
and outstanding questions are whether bacteria and parasites
possess mechanisms to block PRR-dependent autophagy
induction and/or IRG autophagy induction.
Microbial Suppression of Autophagosomal Maturation
The greatest threat to an intracellular pathogen imposed by
autophagy is not the process of autophagic sequestration per
se, but rather the danger imposed by delivery to an autolyso-
some. Accordingly, it is not surprising that several viruses and
intracellular bacteria seem to block fusion of the autophagosome
or autophagy protein-dependent fusion of another pathogen-
containing compartment (i.e., phagosome or pathogen-contain-
ing vacuole) with the lysosome (Table 2). For some viruses and
intracellular bacteria, it is argued that autophagosome formation
may enhance intracellularmicrobial survival, replication, or extra-
cellular release (see section below); in such cases, enhanced
autophagy is usually accompaniedbyablock in autophagosomal
maturation (see Table 2). In this manner, microbes may ‘‘avail
themselves’’ of promicrobial functions of autophagy while simul-
taneously blocking autophagy’s antimicrobial functions (Figure 3,
bottom panel).
Perhaps the earliest described example of this concept was
with Porphyromonas gingivalis, a bacterial periodontal pathogen
that also localizes to atherosclerotic plaques. Based largely on
electron and light microscopy studies, this organism is believed
to traffic to autophagosomes as a mechanism of evading the
conventional endocytic trafficking to lysosomes (Dorn et al.,
2001). The bacterial determinants that direct this trafficking
and the precise details of the cellular trafficking events in
infected cells are not yet defined. In the case of Legionella
pneumophila infection, soluble bacterial type IV secretion prod-
ucts are sufficient to induce autophagy, the bacterial replication
vacuoles have autophagy markers early after infection, and it is
postulated that the bacteria delays autophagosome maturation,
allowing time for the bacteria to differentiate into an acid-tolerant
form (Amer and Swanson, 2005). A somewhat similar scenario
is postulated for Coxiella burnetii replicative vacuoles and Ana-
plasma phagocytophilum bacterial replicative inclusions; both
structures contain autophagosomal but not lysosomal markers
(Beron et al., 2002; Niu et al., 2008; Romano et al., 2009), sug-
gesting that the bacteria possess an as of yet unidentified mech-
anism to block or at least delay autophagosomal fusion with the
lysosome. An important area of future research will be to identify
specific bacterial factors that interfere with autophagosomal
maturation; presumably, pharmacological inhibition of such
targets would result in a substantial decrease in the survival of
intracellular bacteria that seek refuge in ‘‘arrested’’Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 535
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Microbe
Host organism/
cell type
Autophagy genes or
autophagy signals
Effects on host-pathogen
interactions References
VIRUSES
RNA viruses
Alphaviridae
Sindbis virus Mice (neurons) beclin 1 Enforced neuronal Beclin 1
expression reduces CNS
viral replication, neuronal cell
death, and animal mortality
Liang et al., 1998
Rhabdoviridae
Vesicular stomatitis virus Drosophila Atg8, Atg7, Atg12, Atg18 Autophagy gene silencing
increases viral replication
in vivo and decreases fly
survival
Shelly et al., 2009
Tobamoviruses
Tobacco mosaic virus
(TMV)
Plants BECLIN 1, ATG3, ATG7,
VPS34
Autophagy gene silencing
increases TMV local
replication and spread of
programmed cell death
in vivo
Liu et al., 2005
DNA viruses
Herpesviridae
Herpes simplex virus 1
(HSV-1)
Mice beclin 1 Role for autophagy gene in
protection against lethal
encephalitis inferred by
neuroattenuation of mutant
virus that cannot inhibit
Beclin 1 autophagy function
Orvedahl et al., 2007
BACTERIA
Gram-positive cocci
Staphylococcus aureus Mouse embryonic
fibroblasts (MEFs)
Atg5 Atg5 deletion inhibits
bacterial degradation in
autolysosomes, leading to
delayed bacterial clearance
and increased bacterial
multiplication
Amano et al., 2006
Group A Streptococcus MEFs Atg5 Atg5 deletion inhibits
bacterial degradation in
autolysosomes, leading to
delayed bacterial clearance
and increased bacterial
multiplication
Nakagawa et al., 2004
Gram-positive bacilli
Listeria monocytogenes MEFs Atg5 Atg5 deletion increases
replication of bacterial
phospholipase mutants
Py et al., 2007
Mice (macrophages) Atg5 (macrophages) Macrophage Atg5 required
for in vivo resistance in mice
Zhao et al., 2008
Drosophila Atg5, Atg1,
peptidoglycan-
recognition
protein (PGRP)
Autophagy gene silencing
results in failure to control L.
monocytogenes replication
in hemocytes in vitro or in
intact fly; PGRP required to
signal autophagy-mediated
resistance
Yano et al., 2008
Bacillus anthracis Mouse macrophage
cell line
Autophagy induction may
protect cells against
anthrax lethal toxin
Tan et al., 2009536 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.
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Microbe
Host organism/
cell type
Autophagy genes or
autophagy signals
Effects on host-pathogen
interactions References
Gram-negative bacilli
Burkholderia pseudomallei Mouse macrophage cell
lines and embryonic
fibroblasts
Autophagy induction
decreases intracellular
bacterial survival (but no
effect of Atg5 deletion in
MEFs on bacterial survival)
Cullinane et al., 2008
Helicobacter
pylori
Human gastric
epithelial cells
Autophagy inhibition
increases vacuolating toxin
stability and toxin-mediated
cellular vacuolation
Terebiznik et al., 2009
Human monocytic cells Autophagy inhibition
enhances and autophagy
activation suppresses
intracellular bacterial
multiplication
Wang et al., 2009b
Pseudomonas
syringae pv. tomato
Arabidopsis thaliana ATG6 ATG6 silencing in plants
results in increased
spreading programmed cell
death and bacterial virulence
Patel and Dinesh-Kumar,
2008
Salmonella enterica MEFs; epithelial cells Atg5 Atg5 deletion results in
increased intracellular
bacterial growth
Birmingham et al., 2006
Shigella flexneri Dog kidney epithelial
cells and MEFs
Atg5 (in MEFs) IcsB mutant bacteria are
targeted by autophagy,
leading to decreased
intracellular bacterial
multiplication
Ogawa et al., 2005
Vibrio cholerae Human intestinal
cell lines; MEFs
Atg5 (in MEFs) Autophagy protects against
toxic effects of bacterial
secreted pore-forming toxin,
Vibrio cholerae cytolysin
Gutierrez et al., 2007
Mycobacteria
Mycobacterium
tuberculosis
Bacillus Calmette-Guerin
Mouse and human
primary macrophages
and macrophage
cell lines
Atg5 (macrophages
from Atg5Flox/Flox
LysM-Cre mice)
Atg5 required for
autophagic killing
of mycobacteria
in macrophages
Zhao et al., 2008
IFNg and immunity-
related GTPases
(mouse LRG-47,
human IRGM),
signaling through P2X7
Autophagy induction by
immune signaling,
starvation, or TOR inhibition
increases mycobacterial
targeting to
phagolysosomes and
decreases mycobacterial
intracellular survival
Alonso et al., 2007;
Biswas et al., 2008;
Gutierrez et al., 2004;
Singh et al., 2006
Th1 cytokines
activate and Th2
cytokines inhibit
autophagy
IL-4 and IL-13 inhibit IFNg-
or starvation-induced
autophagic elimination
of mycobacteria
Harris et al., 2007
PROTOZOA
Toxoplasma gondii Mice (macrophages) Atg5 Macrophage Atg5 required
for in vivo resistance in mice;
mechanism believed to
be autophagosome-
independent recruitment of
Irga6 to parasitophorous
vacuole
Ling et al., 2006;
Zhao et al., 2008Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 537
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Microbe Adaptation
Effects on host-pathogen
interactions
Microbial virulence
factor/mechanism References
VIRUSES
RNA viruses
Picornaviridae
Poliovirus Infection induces formation
of LC3-positive double
membranes
Proposed mechanism for
nonlytic virus egress
Poliovirus 2BC and 3
proteins induce
GFP-LC3 colocalization
with LAMP1
Jackson et al., 2005;
Taylor and Kirkegaard,
2007
Coxsackievirus B3, B4
(CVB3, CVB4)
CVB3 infection induces
early but not late stages
of autophagy; CVB4
infection induces
autophagy in neurons
May increase viral
replication or yields
Calpain-dependent
(CVB4)
Wong et al., 2008;
Yoon et al., 2008
Flaviviridae
Dengue virus Infection induces
autophagy
Increases viral yields;
colocalization of LC3,
viral dsRNA, and
endosomal marker may
indicate association of
viral replication complex
with amphisomes
Unknown Lee et al., 2008;
Panyasrivanit
et al., 2009
Hepatitis C virus Infection induces early
but not late stages
of autophagy in
hepatocyte cell lines
Increases HCV replication
(without colocalization
of viral proteins and
autophagosomes)
Activation of
unfolded protein
response
Ait-Goughoulte
et al., 2008;
Sir et al., 2008
Pestiviridae
Bovine viral diarrheal virus Incorporation of cellular
LC3 into viral genome
through RNA
recombination
Enhances viral replication
and viral cytopathic
effects and causes lethal
mucosal disease in cattle
Viral LC3 in genome
facilitates viral
polyprotein processing
Meyers et al., 1998
Orthomyxoviridae
Influenza A virus Infection increases
autophagy and
autophagic flux
May increase viral
replication or yields
Unknown Zhou et al., 2009
Reoviridae
Rotavirus Viral nonstructural protein
NSP4 localizes with
LC3 but not LAMP1
Postulated to play a role
in viral morphogenesis,
possibly by creating lipid
membrane scaffold for
formation of viroplasms
Unknown Berkova et al., 2006
Lentiviridae
HIV-1 Infection inhibits
autophagy in primary
CD4+ lymphocytes and
in macrophage cell lines
Proposed mechanism
of viral evasion of
innate immunity
Unknown Zhou and Spector, 2008
Virus may utilize Atg
proteins for replication
in HeLa cells
Proposed mechanism of
viral utilization of autophagic
machinery for replication
Unknown Brass et al., 2008
Infection induces
autophagy gene-
dependent cell death
in bystander cells
Proposed mechanism
of CD4+ T cell depletion
HIV envelope protein
triggers autophagy in
bystander lymphocytes
by binding to CD4 and
CXCR4 through receptor
signaling-independent
mechanisms thought to
involve fusogenic
activity of gp41
Denizot et al., 2008;
Espert et al., 2006538 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.
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Microbe Adaptation
Effects on host-pathogen
interactions
Microbial virulence
factor/mechanism References
Infection induces early
stages of autophagy and
inhibits autophagosomal
maturation in
macrophages
Proposed mechanism
for increasing HIV yields
HIV Gag interacts with
the LC3 autophagy
protein to augment
Gag processing; HIV
Nef binds to Beclin 1 and
inhibits autophagosome
maturation
Kyei et al., 2009
DNA viruses
Herpesviridae
Herpes simplex virus 1
(HSV-1)
Infection inhibits
autophagy in neurons
Confers neurovirulence HSV-1 protein ICP34.5
inhibits PKR signaling
and binds to Beclin 1 to
block autophagy
Orvedahl et al., 2007;
Tallo´czy et al., 2002
Bovine herpesvirus
type 1 (BHV-1)
BHV-1 WT virus induces
apoptosis in MDCK cells,
whereas BHV-1 bICP0
mutant virus induces
nonapoptotic cell death
with autophagy
Proposed mechanism of
regulating of cell death
BHV-1 bICP0 may inhibit
autophagy
Geiser et al., 2008
Human cytomegalovirus
(HCMV)
Infection inhibits
autophagy in primary
fibroblasts
Activates mTOR
pathway and
rapamycin-insensitive
signals
Chaumorcel et al., 2008
g-herpesviruses
KSHV, murine g-HV68 Viral Bcl-2-like proteins
inhibit autophagy
Unknown KSHV vBcl-2 and g-HV68
M11 inhibit autophagy by
binding to Beclin 1
Ku et al., 2008b;
Pattingre et al., 2005;
Sinha et al., 2008
Epstein-Barr virus (EBV) EBV LMP1 protein
induces autophagy
Proposed mechanism
to decrease LMP1 levels
and block its cytostatic
effects on B cells
Unknown Lee and Sugden, 2008
Hepadnaviridae
Hepatitis B virus HBV X protein
transfection enhances
autophagy in
hepatocytes
Unknown HBV X protein increases
Beclin 1 promoter activity
Tang et al., 2009
BACTERIA
Intracellular pathogens
Gram-positive bacilli
Listeria monocytogenes Prevents or evades
autophagic uptake
May enable cytosolic
bacteria to escape
lysosomal degradation
Bacterial Prf1-regulated
factors, including ActA
and phospholipases,
function in autophagy
evasion
Birmingham et al., 2007;
Py et al., 2007
Prevents acidification
of autophagy-dependent
spacious Listeria-
containing phagosomes
(SLAPs)
May allow persistent
intravacuolar infection
in host macrophages
Listeriolysin O, a
pore-forming toxin
and virulence factor,
is essential for SLAP
formation
Birmingham et al., 2008
Gram-negative coccobacilli
Coxiella burnetii Coxiella phagosomes
(CPh) and Coxiella
replicative vacuoles
(CRVs) colocalize
with LC3 autophagy
marker
Interaction between
Coxiella and autophagic
pathway may delay
lysosomal enzyme
recruitment to CPh
Bacterial protein
synthesis required
for CRV formation
and LC3 colocalization
Beron et al., 2002;
Romano et al., 2009
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Microbe Adaptation
Effects on host-pathogen
interactions
Microbial virulence
factor/mechanism References
Francisella tularensis Francisella enters
LC3-positive vacuoles
after intracytoplasmic
replication in murine
macrophages
Postulated to allow
cytoplasmic bacteria
to regain access to
endocytic compartment
to promote bacterial
egress through
exocytosis (also
proposed to be source
for tularemic MHC II
antigen presentation)
Unknown Checroun et al., 2006;
Hrstka et al., 2007
Downregulates expression
of autophagy genes
(ATG4A, 5, 7, 12, 16L2,
BECN1) during
cytoplasmic replication
in human monocytes
Postulated to allow
cytoplasmic bacteria
to escape autophagic
capture
Unknown Butchar et al., 2008
Gram-negative bacilli
Burkholderia pseudomallei Prevents or evades
bacterial colocalization
with LC3 autophagosome
marker
May increase intracellular
bacterial survival
bopA gene required
for bacterial evasion
of autophagy
Cullinane et al., 2008
Legionella pneumophila Legionella replication
vacuoles initially have
the autophagy protein
Atg7 and ER markers
and later have LC3
and lysosomal markers
Postulated that bacteria
slows autophagosome
maturation, allowing time
for bacteria to differentiate
to acid-tolerant form
Soluble bacterial type IV
secretion products are
sufficient to induce
autophagy
Amer and Swanson,
2005
Shigella flexneri Evades autophagic
capture of cytoplasmic
bacteria in epithelial cells
Enhances intracellular
multiplication in
epithelial cells
Bacterial T3SS effector
IcsB blocks autophagic
targeting of the Shigella
protein VirG that is
required for actin-based
motility, through
competitive inhibition
of binding to Atg5
autophagy protein
Ogawa et al., 2005
May induce autophagy
in macrophages
May prevent pyroptotic
death in macrophages
Mechanism of autophagy
induction in macrophages
unknown and negatively
regulated by caspase-1
and Ipaf
Suzuki et al., 2007
Other
Anaplasma
phagocytophilum
Bacterial replicative
inclusions contain
autophagosomal markers
(Beclin 1, LC3) but not
lysosomal markers
May shield bacteria from
endolysosomal pathway
and provide niche to
enhance replication
Unknown Niu et al., 2008
Chlamydia trachomatis Chlamydial inclusion
bodies juxtaposed to
LC3-positive structures
Postulated that bacteria
utilize nutrients derived
from autophagy to
promote intracellular growth
Unknown Al-Younes et al., 2004
Autophagy upregulated
upon active bacterial
growth
Postulated that bacteria
have evolved to neither
need to inhibit nor to
utilize autophagy (since
growth is unaffected
by augmentation
or inhibition of autophagy)
Unknown Pachikara et al., 2009540 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.
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Microbe Adaptation
Effects on host-pathogen
interactions
Microbial virulence
factor/mechanism References
Extracellular pathogens
Gram-negative bacilli
Vibrio parahaemolyticus Induces host autophagy Unknown; proposed
that bacteria may utilize
nutrients released by
autophagically active cells
for their proliferation
Bacterial T3SS effectors
injected into host cell
required for autophagy
induction
Burdette et al., 2008
Bacteria that can invade intracellularly
Gram-positive cocci
Staphylococcus aureus Resides in autophagosomes
after HeLa cell invasion
Postulated to promote
intracellular bacterial
replication, escape into
host cytoplasm, and host
cell killing
Bacterial localization with
autophagosomes requires
agr, a global regulator
of S. aureus virulence
Schnaith et al., 2007
Gram-negative bacilli
Porphyromonas gingivalis Traffics through
autophagosome-like
structures in human
coronary artery
endothelial cells
May prevent formation
of autolysosomes and
pathogen destruction
Unknown Dorn et al., 2001
PROTOZOA
Entamoeba histolytica (Eh)
Entamoeba invadens (Ei)
Parasite autophagy
occurs during proliferation
and encystation (Ei)
May facilitate growth
of trophozoites and
encystation (Ei)
Eh and Ei possess Atg8
but not Atg5-Atg12
autophagy protein
conjugation systems
Picazarri et al., 2008
Leishmania
amazonensis (La)
Leishmania major (Lma)
Leishmania mexicana (Lme)
Parasite may exploit
IFNg-induced host
autophagy response (La)
Increased intracellular La
(but not Lma) parasite load
in macrophages during
starvation or IFNg-induced
autophagy in mouse
strain-specific manner
Mechanism of increased
parasite load with host
autophagy induction
unknown
Pinheiro et al., 2008
Parasite autophagy
promotes differentiation
and survival during
starvation (Lma, Lme)
Parasite autophagy
important for
transformation to
mammalian infective
form and parasite
virulence
Lma Vps and Atg proteins
function in endosome
sorting (Vps4), autophagy
(Vps4, Atg4, Atg8 homologs,
Atg12), and differentiation
(Vps4, Atg4); Lme lysosomal
cysteine peptidases
(CPA, CPB) required
for autophagy
and differentiation
Besteiro et al., 2006;
Williams et al., 2006;
Williams et al., 2009
Toxoplasma gondii Induces autophagy Autophagy promotes
parasite intracellular
proliferation in
nutrient-limiting
conditions in vitro
Calcium-, Atg5-, and
Beclin 1-dependent but
Tor-independent
Wang et al., 2009b
Trypanosoma cruzi Uses host LC3-positive
membranes for cellular
entry
Host autophagy enhances
parasite invasion
Mechanism of host
autophagic membrane
recruitment to parasite
unknown
Romano et al., 2009
Parasite autophagy
promotes differentiation/
development and
survival during starvation
Parasite autophagy
important for parasite
maintenance and
survival
Parasite autophagy
mediated by conserved
Atg proteins (Atg8) but
not Atg5-Atg12 protein
conjugation system
and TOR inhibition
Alvarez et al., 2008
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Microbe Adaptation
Effects on host-pathogen
interactions
Microbial virulence
factor/mechanism References
FUNGI
Aspergillus fumigatus (Af) Fungal autophagy
protein functions in
metal ion homeostasis
Af Atg1 required for
metal ion homeostasis
Richie et al., 2007
Cryptococcus
neoformans (Cn)
Fungal autophagy
activated during
infection in mammalian
cells
Increases fungal
multiplication and
lethal infection in
mouse model
Cn Class III PI3K/Vps34
and Atg8 required for
fungal autophagy
and virulence
Hu et al., 2008
Magnaporthe grisea (Mg) Fungal autophagy
activated during
infection in plants (rice)
Required for fungal spore
(conidium) autophagic
cell death, fungal invasion,
and pathogenesis in plants
Mg Atg8 required for
conidial cell death; Mg Atg1
required for appressorium
invasion in plants
Liu et al., 2007;
Veneault-Fourrey
et al., 2006autophagosomes. It also will be important to determine whether
bacterial evasion of autophagosomal maturation truly contrib-
utes to bacterial pathogenesis using in vivo models of infection
with bacteria that contain mutations in putative antiautophago-
somal maturation bacterial factors. Interestingly, a known Liste-
ria virulence factor, the pore-forming toxin listeriolysin O is
required for the formation of structures termed ‘‘spacious Liste-
ria-containing phagosomes,’’ which require the autophagy
machinery for their formation and fail to acidify, thus potentially
allowing persistent intravacuolar infection in host macrophages
(Birmingham et al., 2008).
The literature to date suggests that several families of viruses
may also block autophagosomal maturation. Poliovirus infection
induces the formation of LC3-positive double-membraned
structures (initially thought to serve as a scaffold for viral RNA
replication and later also postulated to play a role in nonlytic viral
egress from the cell) (Jackson et al., 2005; Taylor and Kirke-
gaard, 2007), but does not induce the formation of autolyso-
somes. Similarly, coxsackie B virus and hepatitis C virus induce
early stages of autophagy, but not late stages of autophagy, in
virally infected cells (Ait-Goughoulte et al., 2008; Sir et al.,
2008; Wong et al., 2008; Yoon et al., 2008), and the rotavirus
nonstructural protein NSP4 colocalizes with LC3 but not lyso-
somal markers (Berkova et al., 2006). One obvious interpreta-
tion of these findings is that these viruses possess specific
mechanisms to prevent autophagosomal fusion with the lyso-
some. However, it is also possible that the lipidation of LC3
(detected by western blot analysis) or membrane localization
of lipidated LC3 (detected by light microscopy), which are the
usual markers of ‘‘early autophagy,’’ do not truly represent
the formation of classical autophagosomes that will invariably
fuse with late endosomes/lysosomes in the absence of specific
autophagosomal maturation-blocking factors. This possibility is
supported by evidence that LC3 dots may represent the tar-
geting of LC3 to structures other than autophagosomes,
including phagosomes, double-membrane scaffolds for viral
RNA replication complexes, or protein aggregates as well as
by evidence that ‘‘autophagy’’ proteins may possess or may
be co-opted for autophagy-independent functions (Virgin and
Levine, 2009).
The identification of specific viral factors that antagonize auto-
phagosomal fusion with the lysosome will be important to distin-542 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.guish between these possibilities, and as suggested for
bacteria, the identification of such factors may represent novel
targets for antiviral therapeutics. Along these lines, a recent
study reports that HIV-1 Nef, an important pathogenic factor
required for HIV disease progression, inhibits autophagic matu-
ration in macrophages through its interaction with the autophagy
protein, Beclin 1 (Kyei et al., 2009) (Figure 3, bottom panel). This
function of Nef inhibits autophagic degradation of HIV biosyn-
thesis intermediates or virions, thereby enhancing HIV virus
yields. These observations provide the first demonstration that
a viral virulence factor can target autophagosomal maturation.
They also underscore the importance of Beclin 1 as a core
component of the autophagic machinery (Figure 1C) that func-
tions both in autophagy initiation (which is antagonized by
herpesvirus-encoded proteins) and autophagosomal maturation
(which is antagonized by HIV Nef). In future studies, it will be
interesting to determine whether Nef has a similar function in
virally-infected CD4 T cells and whether this function of Nef
contributes to HIV pathogenesis. It will also be interesting to
determine whether other viral virulence proteins block the
autophagosomal maturation function of Beclin 1 and/or other
autophagy proteins.
Microbial Avoidance of Autophagic Capture
Another strategy employed by intracellular bacteria to escape the
undesirable fate of lysosomal destruction is to avoid capture by
the autophagosome (Figure 3, bottom panel). While bacteria
that reside in phagosomes or other vacuolar compartments
may seek to avoid lysosomal maturation, the avoidance of auto-
phagic capture may be particularly important for intracellular
bacterial pathogens that escape into the cytoplasm. As noted
above, evasion of autophagic capture has been described for at
least three different intracytoplasmic bacteria, including Shigella
flexneri, L. monocytogenes, and Burkholderia pseudomallei
(Table 2). The first described, most classic example is that of
Shigella escape fromautophagy,which seems to utilize a particu-
larly intriguing scheme to escape autophagic envelopment
(Ogawa et al., 2005). Shigella possesses a surface protein, VirG,
required for actin-based motility that binds to the autophagy
protein Atg5 and thereby targets Shigella to the autophagosome.
However, the bacterial T3SS effector, IcsB, competitively binds
to Atg5, thereby camouflaging its own bacterial target molecule
VirG from autophagic capture. It is not yet known whether
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tions or why such a seemingly inefficient mechanism—i.e., the
need for one bacterial protein to essentially undo the actions of
another protein—evolved. Perhaps we are seeing microbial
adaptation to mammalian autophagy in evolutionary progress,
and Shigella will ultimately undergo further adaptations in VirG
itself to avoid capture by Atg5. As the specific identities of
host cell-derived molecular tags for microbial targeting to the
autophagosome become known, another interesting question
will be whether intracytoplasmic bacteria also possess mecha-
nisms to block such host cell tags, in addition to their ownmicro-
bial tags.
Less is known about whether viruses possess specific
mechanisms to avoid autophagic capture. In the case of hepa-
titis C virus (HCV) infection, two studies have shown that the
virus induces early stages of autophagy at least in part by
activating the unfolded protein response (Ait-Goughoulte
et al., 2008; Sir et al., 2008). Yet, late stages of autophagy
(i.e., the formation of autolysosomes) or the colocalization of
HCV with markers of early autophagosomes are not observed.
These observations imply that HCV may not only possess
mechanisms to block autophagosomal maturation (similar to
what presumably happens with poliovirus, coxsackie B, rota-
virus, and HIV) but also mechanisms to block autophagic
capture of HCV. Particularly for viruses such as HCV that
establish persistent infection, it seems likely that future studies
will identify specific molecular mechanisms by which they
evade autophagic capture.
Microbial Utilization of the Host Autophagic Machinery
for Intracellular Survival, Replication, or Cellular Egress
In parallel with strategies to block autophagy induction, autopha-
golysosomal maturation, or autophagic capture, microbes also
have evolved mechanisms to utilize aspects of host autophagy
to their own advantage (Figure 3, bottom panel). Postulated
benefits of host autophagy for microbes include the promotion
of viral replication or morphogenesis via utilization of the
autophagic machinery, the shielding of bacteria from the endoly-
sosomal pathway via the utilization of autophagosomes as
a protective intracellular niche, and the enhanced survival or
growth of bacteria, fungi, or parasites through the provision of
autophagy-generated nutrients. Although in vitro data support
some of these postulates, whether such mechanisms are im-
portant in microbial pathogenesis in vivo remains to be explored,
and there is no current evidence that autophagy gene deletion
in the host attenuates microbial disease. Thus, unlike the
role of host autophagy in protection against infection (in which
autophagy gene deletion exacerbates microbial disease
[Table 1]) or microbial antagonism of autophagy (in which, for
example, HSV-1 evasion of autophagy is essential for lethal
encephalitis [Table 2]), the physiological significance of microbial
utilization of autophagy for ‘‘promicrobial’’ effects remains to be
established.
Several viruses are believed to induce autophagy to foster
their own replication, morphogenesis, cellular egress, or patho-
genicity (Table 2). One theory, originally developed in the context
of poliovirus research, is that double-membrane autophago-
some-like structures (that contain the autophagy protein LC3)
serve as lipid membrane-scaffolds that enhance viral replication
(Jackson et al., 2005). In a somewhat analogous fashion, the rota-virus NSP4 protein, a protein with pleiotropic functions in viral
morphogenesis and pathogenesis, colocalizes with LC3-positive
vesicular compartments and is postulated to play a role in the
formation of viroplasms and/or the packaging of the rotavirus
genome or transcription (Berkova et al., 2006). However, in
poliovirus-infected cells, siRNA-mediated knockdown of the
autophagy genes, LC3 and Atg12, markedly inhibits the release
of infectious virus while only minimally affecting viral replication
(Taylor and Kirkegaard, 2007), suggesting that the primary func-
tion of poliovirus’s utilization of the autophagicmachinerymaybe
for nonlytic viral release. A similar theme is emerging with HIV
infection in macrophages, as pharmacological stimulation of
autophagy increases extracellular viral yields, whereas pharma-
cological or genetic inhibition of autophagy decreases extracel-
lular viral yields (Kyei et al., 2009). Interestingly, the HIV Gag
precursor protein directly interacts with the LC3 autophagy
protein, and this interaction may facilitate Gag processing and
HIV biogenesis, suggesting a potential biosynthetic, rather than
catabolic, role of the host autophagic machinery. For some other
viruses, such as HCV, which induces early stages of autophagy,
but which does not colocalize with autophagosomes or autopha-
gosomal markers (Ait-Goughoulte et al., 2008; Sir et al., 2008), it
is completely unknown how autophagy induction may function
to increase viral RNA levels. Beyond this utilization of autophagic
machinery for enhancing viral production, it is also worth noting
that, in some contexts, the autophagic machinery may play
a role in features associatedwith viral pathogenesis; for example,
at least in vitro, HIV-induced death of bystander lymphocytes
requires the autophagy genes Atg7 and beclin 1 (Espert et al.,
2006).
As noted above, autophagosomes or cellular compartments
that seem to require autophagic machinery for their formation
may provide a safe ‘‘haven’’ for several bacteria, including
L. monocytogenes, C. burnetii, L. pneumophila, A. phagocyto-
philum, and P. gingivalis (Table 2). In parallel with suppression
of autophagosomal fusion with lysosomes and/or acidification
of pathogen-containing compartments, the bacterial autopha-
gosomal-like compartments may enable the bacteria to persist
(and potentially multiply intracellularly) in a nonacidic compart-
ment. It will be interesting to further determine the cellular fate,
ability to persist intracellularly, and ability to replicate intracellu-
larly of such organisms in target cells that lack critical compo-
nents of the autophagy machinery. The enhanced pathogenicity
of L. monocytogenes-infected mice with macrophage-specific
deletion of Atg5 (Zhao et al., 2008) and the wild-type levels of
replication observed in L. pneumophila-infected Dictyostelium
discoideum lacking Atg1, Atg5, Atg6, Atg7, or Atg8 (Otto et al.,
2004) suggest that speculations based upon in vitro studies
regarding the ‘‘microbe-friendly’’ role of autophagy in microbial
replication may not always correlate with the actual role of
autophagy in microbial pathogenesis in vivo. Besides shielding
bacteria from the endolysosomal pathway, it has also been
proposed that bacterial localization to LC3-positive compart-
ments may allow cytoplasmic bacteria to regain access to the
endocytic compartment to promote bacteria egress through
exocytosis (i.e., during Francisella infection) (Checroun et al.,
2006).
Another theory is that autophagy helps ‘‘feed’’ intracellular
pathogens, particularly those that reside in sequestered
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concept emerged decades ago, when it was first reported
that rickettsiae induce the formation of autophagosomes in
polymorphonuclear cells (Rikihisa, 1984), although a later study
suggested that autophagy may be involved in killing rickettsia in
endothelial cells (Walker et al., 1997). In recent years, it has
been postulated that autophagy may function in infected cells
to deliver nutrients to Chlamydia (Al-Younes et al., 2004), Vibrio
parahaemolyticus (Burdette et al., 2008), and T. gondii (Wang
et al., 2009a), thereby enhancing intracellular pathogen survival
and proliferation. As with other beneficial functions of autoph-
agy for microbes, the physiological relevance of these findings
is not yet known. Moreover, somewhat akin to the discrepant
conclusions between in vitro and in vivo studies with Listeria
and Legionella, although T. gondii has impaired growth in
Atg5-deficient MEFs, leading to the conclusion that host cell
autophagy plays a role in promoting parasite growth through
nutrient recovery (Wang et al., 2009a), T. gondii has increased
virulence in mice with macrophage-specific deletion of Atg5
(Zhao et al., 2008).
Microbial Autophagy
Pathogens such as protozoans, fungi, and helminths are them-
selves eukaryotes and hence have their own autophagic
machinery (Figure3, top right panel). Anemergingareaof research
in microbial pathogenesis is the function of autophagy directly
within such eukaryotic pathogens. The molecular machinery of
autophagy was originally identified in genetic screens performed
in the yeast S. cerevisiae, and autophagy is also present in
disease-causing fungi, as well as in disease-causing protozoans
and helminths. Recent analyses of autophagy in eukaryotic path-
ogens reveals some interesting common themes, including (1) the
identification of potential differences between microbial autoph-
agy and host autophagy in terms of what constitutes the core
autophagic machinery and (2) the identification of an essential
role for microbial autophagy in stress adaptation and develop-
ment, both of which may be important for mammalian infectivity
and virulence.
The Molecular Machinery of Microbial Autophagy
A critical question is whether the autophagic machinery truly
differs in certain pathogenic protozoans from that found in yeasts
and mammalian cells, or whether the lack of apparent structural
homology in some autophagy genes has resulted in the mere
failure of ‘‘genome mining’’ to identify conserved components.
In yeast (S. cerevisiae), 17 genes encoding proteins comprising
the core machinery of autophagy have been identified (Suzuki
and Ohsumi, 2007), most of which are conserved in higher
eukaryotes. Interestingly, two protozoan parasite pathogens,
Entamoeba and Trypanosoma cruzi, are reported to contain all
of the major genes of the Atg8 conjugation system (e.g., Atg3,
Atg4, Atg7, Atg8) but to lack the entire Atg5-Atg12 conjugation
system (Alvarez et al., 2008; Picazarri et al., 2008). This observa-
tion raises the interesting possibility that either the Atg5-Atg12
protein conjugation system is not absolutely essential for autoph-
agy or that autophagy in these organisms is somehow qualita-
tively different from that in other eukaryotic organisms. However,
a recent study found an atypical Atg12-like protein encoded
by Leishmania major, which, when truncated before a scissile
C-terminal glycine, complements Atg12 deficiency in yeast, as544 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.well as more typical Atg5 and Atg10 proteins that restore auto-
phagy in atg5D and atg10D yeast (Williams et al., 2009). These
three Leishmania-encoded Atg12, Atg5, and Atg10 proteins
have syntenic homologs inTrypanosomabruci andTrypanosoma
cruzi (Williams et al., 2009), suggesting that perhaps the Atg5-
Atg12 protein conjugation systems are present but have been
‘‘missed’’ in certain protozoan organisms. Future studies are
required to address this possibility and determine whether or
not fundamental differences exist between the core autophagic
machinery in certain protozoan pathogens and other eukaryotic
organisms.
Microbial Autophagy in Microbial Pathogenesis
Two major functions of microbial autophagy may be relevant
to microbial pathogenesis: the requirement for fungal and
protozoan autophagy for survival during nutrient stress and
the requirement for protozoan autophagy in developmental
transitions to mammalian infective forms. Of potential medical
relevance, autophagy in the dimorphic human fungal path-
ogen, Cryptococcus neoformans, is important for intracellular
survival in macrophages (which is postulated to represent
nutrient self-supplying function in the environment of a
nutrient-poor phagosome) and for virulence, since deletion of
the fungal class III PI3K VPS34 gene or ATG8 knockdown
results in decreased replication and lethality in a mouse model
of cryptococcosis (Hu et al., 2008) (Figure 3, top right panel).
Thus, it will be interesting to see whether it is possible to
specifically target the cryptococcal but not mammalian auto-
phagic machinery in the treatment of human cryptococcal
disease. For protozoan parasites, the autophagic machinery
has been shown as essential for (Figure 3, top right panel):
(1) Entamoeba to undergo the developmental transition from
the trophozoite to the cyst stage, a process essential for its
transmission and reinfection (Picazarri et al., 2008); (2) Leish-
mania to differentiate into the infective metacyclic promasti-
gote form (Besteiro et al., 2006; Williams et al., 2006, 2009);
and (3) Trypanosoma cruzi to differentiate into the infective
metacyclic trypomastigote (Alvarez et al., 2008). These high-
density and/or low-nutrient-dependent stress-induced differ-
entiation events allow the parasites to transition from a form
adapted to survive in insects to a form capable of infecting
mammalian hosts. While it is not yet clear whether autophagy
continues to be important for parasite differentiation inside the
mammalian host, Leishmania mutants lacking lysosomal
cysteine peptidases and defective in autophagy are also
defective in differentiation and lack virulence in macrophages
and mice. Efforts to target lysosomal cysteine peptidases
and/or the Atg4 protease as treatment of T. cruzi caused Cha-
gas disease, and Leishmanias are being considered (Alvarez
et al., 2008; Williams et al., 2006).
Conclusion
A number of key recent studies have expanded the scope of
autophagy’s role in immunity from its original incarnation as
a putative antimicrobial defense mechanism to a full-range
immunological process that participates in innate immunity,
adaptive immunity, and inflammation. The ability of autophagy
to control intracellular microbes, initially documented only
in vitro or in ex vivo experiments, has now been confirmed
in in vivo models of infection. In support of the importance of
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evident that highly evolved intracellular pathogens have special-
ized antiautophagy adaptations that allow intracellular parasites
to prevent, block, or elude autophagic elimination. Autophagy is
intertwined with innate immunity regulators and can be stimu-
lated by agonists of innate immunity receptors with feedback
loops that amplify or inhibit recognition of microbial products
or output signals. At an adaptive immunity level, autophagy
controls T cell populations by shaping the naive T cell repertoire
in the thymus and antigen-specific T cells in the periphery. B cells
are likewise affected, while effector cells such as macrophages
can be activated through autophagy. When autophagy is aber-
rant or ‘‘out of sync’’ in central immunological organs versus
the periphery, pathological inflammation can ensue. Coming
full circle, autophagy as a cell-autonomous defense of the host
cell has met its adversarial counterpart in autophagy that occurs
within protozoan and fungal pathogens. Apparently, autophagy
works tirelessly to protect the master eukaryotic cell, often on
both sides of the host-pathogen relationship.
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